Berberine modulates various signaling pathways, including PI3K/Akt, MAPKs, AMPK, STAT3, NF-κB, EGFR, ROS, and HIF-1α, to sensitize cancer cells to a broad spectrum of cancer therapies [26]. This evidence concerns the gene EGFR and cancer.